Xiaoyu Cui

Title: Innovations in Cancer Diagnosis by Xiaoyu Cui

Introduction

Xiaoyu Cui is an accomplished inventor based in Huntington, WV (US). He has made significant contributions to the field of cancer research through his innovative methods for diagnosis and prognosis. His work focuses on the detection of Na/K-ATPase-mediated Src signaling, which plays a crucial role in understanding cancer mechanisms.

Latest Patents

Xiaoyu Cui holds a patent titled "Methods for detecting Na/K-ATPase-mediated Src signaling for diagnosis and prognosis of cancer." This patent outlines methods for diagnosing cancer in a subject by obtaining a biological sample and determining the phosphorylation at a Y260 residue in a Na/K ATPase present in the sample. The comparison of this phosphorylation level to a control allows for effective cancer diagnosis. Additionally, the patent includes methods for detecting a metabolic switch from oxidative phosphorylation to aerobic glycolysis, further enhancing cancer research methodologies. Xiaoyu Cui has 1 patent to his name.

Career Highlights

Xiaoyu Cui is affiliated with Marshall University Research Corporation, where he continues to advance his research in cancer diagnostics. His work is pivotal in developing new techniques that can lead to better patient outcomes.

Collaborations

Xiaoyu collaborates with talented individuals in his field, including Moumita Banerjee and Zijian Xie. Their combined expertise contributes to the innovative research being conducted at Marshall University Research Corporation.

Conclusion

Xiaoyu Cui's contributions to cancer diagnosis through his patented methods demonstrate the importance of innovation in medical research. His work not only enhances our understanding of cancer but also paves the way for future advancements in the field.